Trademark: 79355199
Status Date
Tuesday, August 8, 2023
Registration Number
7129133
Registration Date
Tuesday, August 8, 2023
Filing Date
Wednesday, September 28, 2022
Published for Opposition
Tuesday, May 23, 2023
40 Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
5 Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
1 Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
45 Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
42 Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
The mark consists of two wavy lines resembling double-stranded DNA in navy together with three comet-like figures in orange. The white in the mark is background only and is not claimed as a feature of the mark.
The color(s) navy and orange is/are claimed as a feature of the mark.
Nov 14, 2023
Final Disposition Notice Sent To Ib
Nov 14, 2023
Final Disposition Processed
Nov 8, 2023
Final Disposition Notice Created, To Be Sent To Ib
Aug 8, 2023
Notice Of Registration Confirmation Emailed
Aug 8, 2023
Registered-Principal Register
May 24, 2023
Notification Processed By Ib
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Possible Opposition Sent To Ib
May 3, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 19, 2023
Approved For Pub - Principal Register
Apr 18, 2023
Teas/Email Correspondence Entered
Apr 17, 2023
Correspondence Received In Law Office
Apr 17, 2023
Teas Response To Office Action Received
Mar 7, 2023
Refusal Processed By Ib
Feb 15, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Feb 15, 2023
Refusal Processed By Mpu
Dec 20, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Dec 19, 2022
Non-Final Action Written
Dec 9, 2022
Assigned To Examiner
Nov 29, 2022
Application Filing Receipt Mailed
Nov 23, 2022
New Application Office Supplied Data Entered
Nov 22, 2022
Limitation From Original Application Entered
Nov 17, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
